Answer
Mario Capecchi and Oliver Smithies shared the Nobel Prize with Martin Evans for their groundbreaking work on gene targeting in embryonic stem cells. This technique revolutionized the study of gene function and the development of new therapies for genetic diseases. Their research paved the way for gene editing technologies like CRISPR-Cas9, which have further transformed biomedical research and hold immense potential for treating a wide range of diseases.